Lifestyle Medical Network (LMNK) 10-Q 27 Apr 15 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Apr. 24, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	LIFESTYLE MEDICAL NETWORK, INC.
Entity Central Index Key	1307140
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Document Type	10-Q
Document Period End Date	30-Sep-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q3
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		25,835,101

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2014	Dec. 31, 2013
CURRENT ASSETS:
Cash and cash equivalents	$723	$19,974
Loan receivable - net of allowance of $42,500
Prepaid expenses	16,000	3,750
Total Current Assets	16,723	23,724
Property, plant and equipment - net	1,992	2,667
Intangible assets - net	90,284	94,448
Deposit on acquisition	100,000
Other assets	6,000	6,000
TOTAL ASSETS	214,999	126,839
CURRENT LIABILITIES:
Short-term debt to related parties	1,050,905	779,133
Short-term debt	251,000	176,000
Accounts payable and accrued expenses	91,811	88,310
Total Current Liabilities	1,393,716	1,043,443
Commitments and Contingencies
STOCKHOLDERS' DEFICIENCY:
Common stock, $.001 par value, 200,000,000 shares authorized; 26,085,101 and 25,835,101 shares issued and 26,084,983 and 25,834,983 shares outstanding at September 30, 2014 and December 31, 2013, respectively	26,085	25,835
Additional paid-in-capital	7,255,810	7,112,725
Accumulated deficit during the development stage	-8,451,375	-8,045,927
Less: Cost of common stock in treasury, 118 and 118 shares at September 30, 2014 and December 31, 2013, respectively	-9,237	-9,237
Total Stockholders' Deficiency	-1,178,717	-916,604
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	$214,999	$126,839

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Balance Sheets
Allowances for bad debts	$42,500	$42,500
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	26,085,101	25,835,101
Common stock, shares outstanding	26,084,983	25,834,983
Common stock in treasury, shares	118	118

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Statements of Operations
Revenues
Costs and expenses:
Selling, general and administrative expenses	125,010	95,830	348,448	283,455
Total Costs and expenses	125,010	95,830	348,448	283,455
Loss from operations	-125,010	-95,830	-348,448	-283,455
Other income (expense):
Interest expense	-12,375	-1,875	-57,000	-5,625
Total Other income (expense)	-12,375	-1,875	-57,000	-5,625
Loss from operations before provision for income taxes	-137,385	-97,705	-405,448	-289,080
Provision for income taxes
Net loss	($137,385)	($97,705)	($405,448)	($289,080)
Loss per common share	($0.01)	$0	($0.01)	($0.01)
Weighted average common shares outstanding - basic and diluted	26,085,101	25,280,753	26,053,965	25,236,420

CONSOLIDATED_STATEMENT_OF_STOC

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY) (Unaudited) (USD $)	Total	Common Stock	Additional Paid In Capital	Retained Earnings (Deficit)	Treasury Stock
Beginning balance at Dec. 31, 2012	($672,709)	$25,205	$6,934,025	($7,622,702)	($9,237)
Beginning balance, Shares at Dec. 31, 2012		25,205,101
Issuance of common stock as incentive for debt	10,000	500	9,500
Issuance of common stock as incentive for debt, Shares		500,000
Issuance of common stock for services	11,550	130	11,420
Issuance of common stock for services, Shares		130,000
Amortization of warrants issued for services	157,780		157,780
Net loss	-423,225			-423,225
Ending balance at Dec. 31, 2013	-916,604	25,835	7,112,725	-8,045,927	-9,237
Ending balance, Shares at Dec. 31, 2013		25,835,101
Issuance of common stock as incentive for debt	25,000	250	24,750
Issuance of common stock as incentive for debt, Shares		250,000
Amortization of warrants issued for services	118,335		118,335
Net loss	-405,448			-405,448
Ending balance at Sep. 30, 2014	($1,178,717)	$26,085	$7,255,810	($8,451,375)	($9,237)
Ending balance, Shares at Sep. 30, 2014		26,085,101

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net loss	($405,448)	($289,080)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization	4,164	4,164
Depreciation	675
Non-cash compensation	143,335	129,885
Changes in operating assets and liabilities:
Increase in prepaid expenses	-12,250	453
Increase in other assets
Increase (decrease) in accrued expenses	3,501	82,715
Expenses paid on behalf of the company		21,833
Net Cash Used In Operating Activities	-266,023	-50,030
Cash flows from investing activities:
Deposit on acquisition	-100,000
Net Cash Used In Investing Activities	-100,000
Cash flows from financing activities:
Proceeds from related parties	271,772	20,000
Proceeds from short-term debt	75,000	30,000
Net Cash Provided by Financing Activities	346,772	50,000
Net increase (decrease) in cash	-19,251	-30
Cash and cash equivalents - Beginning of year	19,974	38
Cash and cash equivalents - End of period	$723	$8

Description_of_Business_and_Su

Description of Business and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2014
Description of Business and Summary of Significant Accounting Policies [Abstract]
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	1	DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	The consolidated balance sheet as of September 30, 2014 and the consolidated statements of operations, stockholders' deficiency and cash flows for the periods presented have been prepared by Lifestyle Medical Network, Inc. and Subsidiaries (the "Company" or "Lifestyle") and are unaudited. The consolidated financial statements are prepared in accordance with the requirements for unaudited interim periods, and consequently, do not include all disclosures required to be made in conformity with accounting principles generally accepted in the United States of America. In the opinion of management, all adjustments (consisting solely of normal recurring adjustments) necessary to present fairly the financial position, results of operations, changes in stockholders' deficiency and cash flows for all periods presented have been made. The information for the consolidated balance sheet as of December 31, 2013 was derived from audited financial statements of the Company.
	Organization
	Lifestyle Medical Network Inc. and Subsidiaries (the “Company” or “Lifestyle”) was incorporated in the State of Nevada. The Company directs its operations through its subsidiaries. During 2011, the Company sold its media business in Moldova in exchange for 730,000 of its common shares. In December 2011, the Company entered into an exchange agreement and purchased Lifestyle Medical Corp. ("LMC"). In connection with the acquisition, the operations of the Company are now the operations of LMC. LMC operates its business under a License related to patent rights used in connection with the operations of medical clinics that provide medical services related to men's health, with proprietary trade names and logo designs.
	On July 11, 2012, through a merger with the Company's wholly-owned Nevada subsidiary, Lifestyle Medical Network Inc., the name of the Company was changed to Lifestyle Medical Network Inc.  This corporate action was permitted to be taken by the Company’s Board of Directors without stockholder approval under Nevada law. In the merger, which was for the sole purpose of changing the Company’s name, there were no other changes to the Articles of Incorporation or any changes to the capital stock of the Company, or to its By-Laws or its officers and directors. The change of the corporate name was approved by FINRA, effective for trading purposes July 31, 2012.
	Acquisition of Lifestyle Medical Corporation
	On December 29, 2011, the Company closed an acquisition of 100% of the outstanding shares of Lifestyle Medical Corp., incorporated under the laws of Florida, pursuant to an Exchange Agreement, executed on that date, by and between the Company and Lifestyle Medical Corporation. The consideration paid by the Company for the acquisition of LMC was 5,000,000 shares of the Company's common stock paid to the holders of 100% of the outstanding shares of LMC, valued at $2,500,000, the fair market value at the date of issuance.
	LMC was incorporated under the laws of the state of Florida on November 14, 2011, and on December 27, 2011 (immediately prior to LMC’s acquisition by the Company) acquired 100% of the membership interests in Elite Professional IP Licensing, LLC, a Delaware limited liability company formed on October 8, 2010 (“Elite”), and 100% of the outstanding shares of Regional Professional Alliance, Inc., a Florida corporation incorporated on October 11, 2010 (“RPA”). LMC, Elite and RPA are entities under common control and all three entities have the same ownership. At the time of its acquisition by LMC, Elite was the assignee, pursuant to an assignment effective May 9, 2011 (the “Assignment”), from Worldwide Medassets, Ltd. SAL (“WMA”) of WMA’s rights as licensee under an October 5, 2010, License Agreement (the “License” or "License Agreement") with Modular Properties Limited, Inc., as Licensor (“MPL”). The fee that was payable to WMA in connection with the Assignment of the MPL License was $6,000,000, represented by a secured promissory note dated May 7, 2011 the (“WMA Note”) in the principal amount of $6,000,000 issued by Saddleworth Ventures, LLC, a Florida limited liability company ("Saddleworth Ventures") to WMA. At that time the ownership of Saddleworth Ventures was identical to the ownership of Elite (now a wholly-owned subsidiary of the Company). Mr. Christopher Smith, the Company's Chief Executive Officer, had a 25.6% equity interest in Elite at the time of the assignment of the license and the same interest in Saddleworth Ventures. As of the December 27, 2011 acquisition of Elite by LMC, $3,000,000 of the amount owing under the WMA Note had been paid to WMA.
	For accounting purposes only, the transactions between LMC with Elite and RPA and the transaction between EMH and LMC were treated as a recapitalization of LMC, as of December 29, 2011, with LMC as the acquirer. The financial statements prior to December 29, 2011, are those of LMC and reflect the assets and liabilities of LMC at historical carrying amounts. The financial statements show a retroactive restatement of LMC's historical stockholders' equity to reflect the equivalent number of shares issued to LMC.
	Acquisition by the Company of the Rights to the License with MPL
	As of January 5, 2012, Saddleworth Ventures, with the consent of WMA, assigned the WMA Note to Saddleworth Consulting, LLC, a Florida limited liability company (“Saddleworth Consulting”), and Saddleworth Consulting assumed all obligations under the WMA Note, $3,000,000 of the principal amount of which was outstanding as of the date of the assignment.
	Pursuant to a Stock Purchase Agreement, dated as of February 8, 2012, between the Company and Saddleworth Consulting, the Company agreed to issue 19,000,000 shares of its common stock to Saddleworth Consulting in exchange for the satisfaction by Saddleworth Consulting of the outstanding $3,000,000 principal balance and accrued interest on the WMA Note. In consideration of the stock issuance, such outstanding principal balance and all obligations under the WMA note to WMA were satisfied by Saddleworth Consulting.
	Going Concern
	The consolidated financial statements for the nine months ended September 30, 2014 have been prepared on a going concern basis which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. The Company has a past history of recurring losses from operations and is a development stage company. The Company will require additional funding to execute its future strategic business plan. Successful business operations and its transition to attaining profitability are dependent upon obtaining additional financing and achieving a level of revenue to support its cost structure. These factors raise substantial doubt about the Company's ability to continue as a going concern.
	Management has signed a letter of intent to purchase the assets and operations of a group of six primary care and specialty medical clinics in Houston, Texas, including the real estate properties of the clinics. Management intends to make further acquisitions of other medical clinics during 2014.
	Management believes these acquisitions will be profitable and the cash flows from these operations will enable the Company to fund the operations of the consolidated group over the next twelve months. Therefore, the annual financial statements continue to be prepared on a going concern basis.
	Significant Accounting Policies
	The Company’s significant accounting policies are summarized in Note 1 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.  There were no significant changes to these accounting policies during the nine months ended September 30, 2014 and the Company does not expect that the adoption of other recent accounting pronouncements will have a material impact on its financial statements.

Recently_Enacted_Accounting_St

Recently Enacted Accounting Standards	9 Months Ended
	Sep. 30, 2014
Recently Enacted Accounting Standards [Abstract]
RECENTLY ENACTED ACCOUNTING STANDARDS	2	RECENTLY ENACTED ACCOUNTING STANDARDS
	In June 2014, the FASB issued ASC 2014-10, “Development Stage Entities (Topic 915): Elimination of Certain Financial Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consideration”. The guidance eliminates the definition of a development stage entity thereby remaining the incremental financial reporting requirements from U.S. GAAP for development stage entities, primarily presentation of inception to date financial information. The provisions of the amendments are effective for annual reporting periods beginning after December 15, 2014, and the interim periods therein. However, early adoption is permitted. Accordingly, the Company has adopted this standard as of September 30, 2014.

Intangibles

Intangibles	9 Months Ended
	Sep. 30, 2014
Intangibles [Abstract]
INTANGIBLES	3	INTANGIBLES
	The MPL License Agreement
	The MPL License Agreement, under which the Company's wholly-owned subsidiary, Elite, is the licensee pursuant to the Assignment from WMA, provides for the license of medical services, operational systems, manuals, certain names and logo designs and other intellectual property in connection with the operation of medical clinics that provide services related to men’s health within the territory of the continental United States (the “Licensed Rights”). The License Agreement provides for a fee of 6% of gross receipts of Licensee, payable quarterly. The term of the License Agreement is for twenty (20) years from the effective date, May 9, 2011. The Company plans to establish new medical clinics or acquire existing clinics, as well as to provide consulting services to medical clinics utilizing the Licensed Rights.
	Intangibles are the value of the MPL license. Amounts assigned to this intangible were determined by management. Management considered a number of factors in determining the allocations, including valuations and independent appraisals. The intangibles are being amortized over 19.5 years, the life of the license.
	As of December 31, 2012, management concluded the fair value of the license should be reduced to $100,000 based on a market analysis and the failure of the Company to open any clinics during 2012 and no contracts for the use of the license in the foreseeable future. The Company recorded an impairment charge of $5,392,308 which is included in the Company’s consolidated statement of operations for the year ended December 31, 2012.
	The components of intangible assets are as follows:
		License Agreements
		Balance January 1, 2011	$	-
		Acquisition of license		6,000,000
		Amortization for the period May 8, 2011 through December 31, 2011		(200,000	)
		Balance December 31, 2011		5,800,000
		Amortization for the year ended December 31, 2012		(307,692	)
		Impairment charge		(5,392,308	)
		Balance December 31, 2012		100,000
		Amortization for the year ended  December 31, 2013		(5,552	)
		Balance December 31, 2013		94,448
		Amortization for the nine months ended September 30, 2014		(4,164	)
		Balance September 30, 2014	$	90,284
	Amortization expense for the nine months ended September 30, 2014 and 2013 amounted to $4,164 and $4,164, respectively.
	Estimated amortization expense for intangible assets for the next five years is as follows:
		Year Ending	Amortization
		December 31,	Expense
		2014	$	1,391
		2015		5,555
		2016		5,555
		2017		5,555
		2018		5,555

Loan_Receivable

Loan Receivable	9 Months Ended
	Sep. 30, 2014
Loan Receivable [Abstract]
LOAN RECEIVABLE		4	LOAN RECEIVABLE
	On February 3, 2012, LMC loaned $32,000 to Health Clinics of Florida, LLC. On April 9, 2012 and August 10, 2012, LMC advanced an additional $10,500. The unsecured notes are interest free and due June 15, 2013. In the event of default, interest on the outstanding balance shall accrue at a rate of ten percent (10%) per annum from the date of the default. The manager of Health Clinics of Florida, LLC is a shareholder of the Company. As of December 31, 2012, the Company recorded a reserve for the full amount of the receivable reducing the balance to $-0-. The bad debt expense of $42,500 is included in the Company’s consolidated statement of operations for the year ended December 31, 2012.

Debt

Debt	9 Months Ended
	Sep. 30, 2014
Debt [Abstract]
DEBT	5	DEBT
	Short-term debt as of September 30, 2014 and December 31, 2013 were as follows:
			September 30,		December 31,
			2014		2013
		Short-term Debt to Related Parties
		Unsecured promissory note, interest free, due April 15, 2015 (1)	$	200,000	$	200,000
		Unsecured promissory note, interest free, due April 15, 2015 (2)		75,000		75,000
		Unsecured promissory note, interest free, due April 15, 2015 (2)		60,000		60,000
		Unsecured promissory notes, interest @ 10% per annum, due April 15, 2015 (3)		75,000		75,000
		Unsecured promissory notes, interest free due April 15, 2015 (4)		347,200		347,200
		Unsecured promissory note, interest free, due on demand (5)		193,705		21,933
		Unsecured promissory note, interest free, due January 15, 2015 (9)		100,000		-
				1,050,905		779,133
		Less: Current portion		1,050,905		779,133
			$	-	$	-
			September 30,		December 31,
			2014		2013
		Short-term Debt
		Unsecured promissory note, interest free, due on demand (6)	$	26,000	$	26,000
		Secured promissory note, interest @ 12% per annum, due December 15, 2014 (7)		150,000		150,000
		Unsecured promissory note, interest @ 10%, due December 15, 2014 (8)		75,000		-
			$	251,000	$	176,000
		Less: Current portion		251,000		176,000
			$	-	$	-
	(1) On January 5, 2012, LMC borrowed $200,000 from the Dellinger Fund, a shareholder of the Company. The note is interest free and has been extended to April 15, 2015. In the event of default, the Dellinger Fund has the right to request and will be granted the issuance of two million shares of the Company's common stock.
	(2) On February 3, 2012 and March 1, 2012, LMC borrowed $75,000 and $60,000, respectively, from the Dellinger Fund, a shareholder of the Company. The unsecured notes are interest free and are due April 15, 2015. In the event of default, interest on the outstanding balance shall accrue at a rate of ten percent (10%) per annum from the date of the default.
	(3) On April 3, 2012, LMC borrowed $75,000 from the Dellinger Fund, a shareholder of the Company. The unsecured note bears interest @ 10% per anum and is due April 15, 2015. In the event of default, interest on the outstanding balance shall continue to accrue at a rate of ten percent (10%) per annum from the date of the default.
	(4) On various dates from March 23, 2012 through November 26, 2012, LMC borrowed $327,200 from the Dellinger Fund, a shareholder of the Company. In February 2013, LMC borrowed an additional $20,000. The unsecured notes are interest free and are due April 15, 2015. In the event of a default, interest on the outstanding balance shall accrue at a rate of ten percent (10%) per annum from the date of the default.
	(5) During the year ended December 31, 2013 and the nine months ended September 30, 2014, Saddleworth Ventures LLC, a related party, paid expenses amounting to $21,933 and $171,772, respectively, on behalf of the Company. These advances are unsecured, interest free and are due on demand.
	(6) On May 13, 2013, LMC borrowed $30,000 from Forbes Investment, LLP. The unsecured note is interest free and payable upon demand. In December 2013, LMC repaid $4,000 against the outstanding balance.
	(7) On October 16, 2013, LMC borrowed $150,000 from Edmund Malits, a shareholder of the Company. The secured note bears interest @ 12% per annum and interest and principal are payable in full on or before February 16, 2014. LMC provided the Corporation’s shell on the OTCBB as collateral for the loan. In addition, LMC issued Edmund Malits 500,000 shares of the Company’s common stock with a fair value of $10,000. The note has been extended to December 15, 2014.
	(8) On February 4, 2014, the Company executed an unsecured promissory note with Curt Maes and received $75,000. The promissory note bears interest @ 10% per annum and both principal and interest are payable on or before December 15, 2014. As additional consideration, the Company issued Curt Maes 250,000 shares of the Company’s common stock valued @ $25,000.
	(9)  In February 2014, the Company received from Saddleworth Ventures an advance of $100,000 that was used as an initial down payment for an acquisition. The advance is interest free and due January 15, 2015.  Saddleworth Ventures has the option to convert the note representing the advance, in whole or in part, into shares of the Company’s common stock at a price of $0.10 per share.
	Interest expense for the nine months ended September 30, 2014 and amounted to $57,000 and $5,625, respectively.

Accounts_Payable_and_Accrued_E

Accounts Payable and Accrued Expenses	9 Months Ended
	Sep. 30, 2014
Accounts Payable and Accrued Expenses [Abstract]
ACCOUNTS PAYABLE AND ACCRUED EXPENSES	6	ACCOUNTS PAYABLE AND ACCRUED EXPENSES
			September 30,		December 31,
			2014		2013
		Interest	$	44,900	$	16,650
		Salaries - Officer		5,000		13,250
		Rent		-		22,418
		Other		41,911		35,992
			$	91,811	$	88,310

Income_Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2014
Income Taxes [Abstract]
INCOME TAXES	7	INCOME TAXES
	The Company adopted the provisions of ASC 740, "Income Taxes", ("ASC 740").  As a result of the implementation of ASC 740, the Company recognized no adjustment in the net liability for unrecognized income tax benefits.  The Company believes there are no potential uncertain tax positions and all tax returns are correct as filed.  Should the Company recognize a liability for uncertain tax positions, the Company will separately recognize the liability for uncertain tax positions on its balance sheet.  Included in any liability for uncertain tax positions, the Company will also setup a liability for interest and penalties.  The Company’s policy is to recognize interest and penalties related to uncertain tax positions as a component of the current provision for income taxes.
	There is no U.S. tax provision due to losses from U.S. operations during the nine months ended September 30, 2014 and 2013.  Deferred income taxes are provided for the temporary differences between the financial reporting and tax basis of the Company's assets and liabilities. The principal item giving rise to deferred taxes is the net operating loss carryforward in the U.S.  Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.  The Company has set up a valuation allowance for losses for certain carryforwards that it believes may not be realized.
	Section 382 of the U.S. Internal Revenue Code imposes an annual limitation on the availability of NOL carryforwards to offset taxable income when an ownership change occurs.  The Company's reverse capitalization meets the definition of an ownership change and some of the NOL's will be limited.

Stockholders_Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2014
Stockholders' Equity [Abstract]
STOCKHOLDERS' EQUITY	8	STOCKHOLDERS' EQUITY
	Pursuant to a Stock Purchase Agreement, dated as of February 8, 2012, between the Company and Saddleworth Consulting, the Company agreed to issue 19,000,000 shares of its common stock to Saddleworth Consulting in exchange for the satisfaction by Saddleworth Consulting of the outstanding $3,000,000 principal balance and $165,000 of accrued interest on the WMA Note. In consideration of the stock issuance, such outstanding principal balance and all obligations under the WMA note to WMA, a shareholder of the Company, were satisfied by Saddleworth Consulting.
	The fair value of the common shares issued amounted to $3,800,000. The Company recorded a loss of $654,657 upon the extinguishment of debt which is included in the Company’s consolidated statement of operations for the year ended December 31, 2012.

StockBased_Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2014
Stock-Based Compensation [Abstract]
STOCK-BASED COMPENSATION		9	STOCK-BASED COMPENSATION
	For the nine months ended September 30, 2014 and 2013 the Company issued -0- and 130,000 shares and recorded compensation expense of $-0- and $11,550, respectively.
	On February 4, 2014, the Company issued Curt Maes 250,000 shares of the Company’s common stock with a fair value of $25,000 as incentive for debt financing.
	In October 2013, the Company issued Edmund Malits 500,000 shares of the Company’s common stock with a fair value of $10,000 as incentive for debt financing.

Warrants

Warrants	9 Months Ended
	Sep. 30, 2014
Warrants [Abstract]
WARRANTS	10	WARRANTS
	On February 6, 2012, the Company issued warrants as compensation to a third party to purchase 2,400,000 shares of the Company's common stock for services performed. The warrants expire February 6, 2017. The estimated value of the compensatory warrants was determined using the Black Scholes pricing model using the following assumptions: Expected term of 3 years, a risk free interest rate of 0.32%, a dividend yield of -0-% and volatility of 432%. The fair value of the warrant amounted to $479,912 to be amortized over 3 years. The Company recorded an expense of $118,335 and $118,335 on the Company’s consolidated statement of operations for the nine months ended September 30, 2014 and 2013, respectively.
	The following table summarizes the changes in warrants outstanding and the related price of the shares of the Company's common stock issued to non-employees of the Company. The warrants were granted in lieu of cash compensation for services performed.
			Shares		Exercise Price
		Outstanding, January 1, 2014		2,400,000	$	0.2
		Granted		-		-
		Expired/Cancelled		-		-
		Exercised		-		-
		Outstanding - period ending September 30, 2014		2,400,000	$	0.2
		Exercisable - period ending September 30, 2014		2,400,000	$	0.2

Related_Party_Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2014
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	11	RELATED PARTY TRANSACTIONS
		a)	During the year ended December 31, 2011, Elite had activities with Saddleworth Ventures LLC, a related party.  The ownership of Saddleworth Ventures is identical to the ownership of Elite.  Saddleworth Ventures assigned the rights to Elite as licensee under the License Agreement with MPL.  In connection with the purchase of the license, $3 million of the $6 million purchase price was paid by the members of Elite on the amount owing under the WMA note.
		b)	The Company entered into a consulting agreement with Saddleworth Ventures LLC.  Consulting fees for the nine months ended September 30, 2014 and 2013 were $-0- and $-0-, respectively.  See Note 12 (a) for further information.
		c)	During the years ended December 31, 2013 and nine months ended September 30, 2014, Saddleworth Ventures LLC paid expenses amounting to $21,933 and $171,772, respectively, on behalf of the Company. These advance are unsecured, interest free and due on demand. As of September 30, 2014, no repayments have been made.
		d)	During the year ended December 31, 2012, the Company received $737,200 in advances from the Dellinger Fund, a shareholder of the Company. During the year ended December 31, 2013, the Dellinger Fund advanced an additional $20,000.  The majority of these advances are interest free.  The Company recorded interest expense for the nine months ended September 30, 2014 and 2013 in the amount of $11,250 and $5,625, respectively, on the advances that were not interest free.  See Note 4 for further information.
		e)	In February 2014, the Company received from Saddleworth Ventures an advance of $100,000 that was used as an initial down payment for an acquisition. The advance is interest free and due January 15, 2015.  Saddleworth Ventures has the option to convert the note representing the advance, in whole or in part, into shares of the Company’s common stock at a price of $0.10 per share.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2014
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES		12	COMMITMENTS AND CONTINGENCIES
	Consulting Agreements
		a)	In January 2012, Lifestyle entered into a consulting agreement with Saddleworth Ventures LLC ("Consultant"). The Consultant will provide services for management consulting, business advisory, shareholder information and public relations. The term of the agreement is for three years. Upon execution of the agreement, Lifestyle issued a payment to the Consultant in the amount of $25,000. Additional cash fees or reimbursement of expenses shall be agreed upon by Lifestyle and the Consultant from time to time during the term of the agreement. Consulting fees for the nine months ended September 30, 2014 and 2013 amounted to $-0- and $-0-, respectively.
		b)	During 2014, 2013 and 2012, Lifestyle entered into various consulting agreements with third parties in connection with business advisory services. For the nine months ended September 30, 2014 and 2013, consulting services amounted to $67,500 and $5,666, respectively.
		c)	On July 1, 2012, Lifestyle entered into an employment agreement with Christopher Smith ("Smith"), the Company's Chief Executive Officer. The term of the agreement is for five years. Lifestyle will pay Smith minimum compensation of $60K per year. Smith will also receive a performance bonus based on a percentage of the Company's net operating profit before income taxes. For the nine months ended September 30, 2014, and 2013, payroll-officer amounted to $45,000 and $45,000, respectively.

Subsequent_Events

Subsequent Events	9 Months Ended
	Sep. 30, 2014
Subsequent Events [Abstract]
SUBSEQUENT EVENTS		13	SUBSEQUENT EVENTS
	Material Agreements
	Dr. Ronald Moomaw, a director of the Company and a licensed physician in the State of Texas, who had been assisting the Company in evaluating the acquisition by the Company of two medical practices in Houston, Texas, has purchased the two medical professional associations, MED-CURE Primary Care Physicians, P.A. and MED-CURE Anti-Aging and Skin Care, P.A. (the “MED-CURE Companies”), effective April 1, 2015. The MED-CURE Companies were purchased by Dr. Moomaw directly from the owner, Dr. Nazmudin Keshwani, for a purchase price of $2,500,000, utilizing local bank financing.
	The MED-CURE Companies between them operate six medical clinics in Houston, of which four are primary care clinics and two are skin care clinics. Dr. Keshwani has entered into employment contracts extending through December 31, 2015, with the MED-CURE Companies as a “physician employee”, pursuant to which he will perform medical services as are required for operations of the clinics. The MED-CURE Companies have agreed to enter into management agreements with the Company which will be effective as of April 1, 2015, pursuant to which the Company, through its subsidiary Lifestyle Texas Medical Management, LLC (“Lifestyle Management”), will provide organizational development, accounting, human resources, computer technical support compliance, scheduling, marketing and advertising, office space, equipment supplies and other management services and will receive an agreed percentage of the gross revenues of the practice group, with adjustments designed to ensure that management fees do not exceed an agreed cap, or that the remaining amounts distributed to the doctors are no less than a specified floor percentage of gross revenues.
	Through our subsidiary, Regional Professional Alliance, Inc. (“Lifestyle Professional Alliance”), a physician’s professional consulting company that provides professional medical consulting services to medical management companies related to matters affecting professional licensure and medical clinic compliance matters for the benefit of clinics managed by Lifestyle Management, we have agreed to enter into a Regional Medical Director Agreement, which will be effective as of April 1, 2015, with Dr. Moomaw, pursuant to which Lifestyle Professional Alliance would provide the services of Dr. Moomaw for the benefit of Lifestyle Management related to oversight and professional medical services coordination of the managed clinics which have entered into management services agreements with Lifestyle Management.
	Through Lifestyle Texas Licensing, LLC (“Lifestyle Licensing”), the Company plans to sublicense to the MED-CURE Companies the non-exclusive right to use, and to sublicense the use of, certain patents, trademarks, trade names, service marks, logos, slogans, trade dress, commercial symbols, operational systems, and other intellectual property rights, in connection with operating and managing medical clinics that provide medical services and/or products of a distinctive character and quality, in particular relating to men’s health.
	Issuance of Warrants
	In connection with the engagement of our director, Dr. Ronald Moomaw, under a Regional Medical Director Agreement with RPA, at a Board of Directors meeting, held on April 17, 2015, the Board authorized the issuance Dr. Moomaw of a seven year stock purchase warrant, expiring April 17, 2022, to purchase 5,000,000 shares of our common stock, at an exercise price of $.09 per share.
	Conversion of Debt
	At the Board meeting held on April 17, 2015, our Board approved the conversion by the Company of $757,200 principal amount plus accrued interest of Company debt held by The Dellinger Fund, into an aggregate of 6,000,000 shares of common stock.
	Refund of Deposit
	On April 10, 2015, the Company received from Dr. Nazmudin Keshwani a refund of the $100,000 deposit made by the Company in February 14, 2014, in connection with the Company’s previous negotiations to acquire the MED-CURE Companies.

Intangibles_Tables

Intangibles (Tables)	9 Months Ended
	Sep. 30, 2014
Intangibles [Abstract]
Components of intangible assets
		Balance January 1, 2011	$	-
		Acquisition of license		6,000,000
		Amortization for the period May 8, 2011 through December 31, 2011		(200,000	)
		Balance December 31, 2011		5,800,000
		Amortization for the year ended December 31, 2012		(307,692	)
		Impairment charge		(5,392,308	)
		Balance December 31, 2012		100,000
		Amortization for the year ended December 31, 2013		(5,552	)
		Balance December 31, 2013		94,448
		Amortization for the nine months ended September 30, 2014		(4,164	)
		Balance September 30, 2014	$	90,284
Estimated amortization expense for intangible assets
		Year Ending	Amortization
		December 31,	Expense
		2014	$	1,391
		2015		5,555
		2016		5,555
		2017		5,555
		2018		5,555

Debt_Tables

Debt (Tables)	9 Months Ended
	Sep. 30, 2014
Debt [Abstract]
Summary of short-term debt			September 30,		December 31,
			2014		2013
		Short-term Debt to Related Parties
		Unsecured promissory note, interest free, due April 15, 2015 (1)	$	200,000	$	200,000
		Unsecured promissory note, interest free, due April 15, 2015 (2)		75,000		75,000
		Unsecured promissory note, interest free, due April 15, 2015 (2)		60,000		60,000
		Unsecured promissory notes, interest @ 10% per annum, due April 15, 2015 (3)		75,000		75,000
		Unsecured promissory notes, interest free due April 15, 2015 (4)		347,200		347,200
		Unsecured promissory note, interest free, due on demand (5)		193,705		21,933
		Unsecured promissory note, interest free, due January 15, 2015 (9)		100,000		-
				1,050,905		779,133
		Less: Current portion		1,050,905		779,133
			$	-	$	-
			September 30,		December 31,
			2014		2013
		Short-term Debt
		Unsecured promissory note, interest free, due on demand (6)	$	26,000	$	26,000
		Secured promissory note, interest @ 12% per annum, due December 15, 2014 (7)		150,000		150,000
		Unsecured promissory note, interest @ 10%, due December 15, 2014 (8)		75,000		-
			$	251,000	$	176,000
		Less: Current portion		251,000		176,000
			$	-	$	-

Accounts_Payable_and_Accrued_E1

Accounts Payable and Accrued Expenses (Tables)	9 Months Ended
	Sep. 30, 2014
Accounts Payable and Accrued Expenses [Abstract]
Schedule of accounts payable and accrued expenses
			September 30,		December 31,
			2014		2013
		Interest	$	44,900	$	16,650
		Salaries - Officer		5,000		13,250
		Rent		-		22,418
		Other		41,911		35,992
			$	91,811	$	88,310

Warrants_Tables

Warrants (Tables)	9 Months Ended
	Sep. 30, 2014
Warrants [Abstract]
WARRANTS			Shares		Exercise Price
		Outstanding, January 1, 2014		2,400,000	$	0.2
		Granted		-		-
		Expired/Cancelled		-		-
		Exercised		-		-
		Outstanding - period ending September 30, 2014		2,400,000	$	0.2
		Exercisable - period ending September 30, 2014		2,400,000	$	0.2

Description_of_Business_and_Su1

Description of Business and Summary of Significant Accounting Policies (Details) (USD $)	0 Months Ended			1 Months Ended	0 Months Ended
	Feb. 08, 2012	Dec. 27, 2011	7-May-11	Dec. 31, 2011	Dec. 29, 2011	Jan. 05, 2012
				Entity
Description of Business and Summary of Significant Accounting Policies (Textual)
Number of entities acquired by company				3
Obligations under the WMA Note						$3,000,000
Number of common shares exchanged in sale of Media business				730,000
Purchase consideration paid to WMA		3,000,000
License fee			6,000,000
Amount of promissory note that used to secure licensing cost			6,000,000
Percentage of equity interest hold by CEO in Elite			25.60%
Stock issued for services to Saddleworth consulting	19,000,000
Outstanding principal balance exchange for the shares by Saddleworth Consulting	3,000,000
Lifestyle Medical Corp [Member]
Description of Business and Summary of Significant Accounting Policies (Textual)
Ownership percentage acquired by company					100.00%
Number of common stock, shares paid to the holders of 100% of the outstanding shares of LMC for purchase consideration					5,000,000
Value of shares that paid for purchase consideration					$2,500,000
Elite Professional IP Licensing LLC [Member]
Description of Business and Summary of Significant Accounting Policies (Textual)
Ownership percentage acquired by company		100.00%
Regional Professional Alliance Inc [Member]
Description of Business and Summary of Significant Accounting Policies (Textual)
Ownership percentage acquired by company		100.00%

Intangibles_Details

Intangibles (Details) (USD $)	0 Months Ended	9 Months Ended		12 Months Ended
	7-May-11	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2011
Components of intangible assets
Intangible assets - net Beginning balance		$94,448	$100,000		$100,000
Acquisition of license	6,000,000
Amortization		-4,164	-4,164
Impairment loss				-5,392,308
Intangible assets - net Ending Balance		90,284		100,000
MPL License Agreement [Member]
Components of intangible assets
Intangible assets - net Beginning balance		94,448	100,000	5,800,000	100,000
Acquisition of license						6,000,000
Amortization		-4,164		-307,692	-5,552	-200,000
Impairment loss				-5,392,308
Intangible assets - net Ending Balance		$90,284		$100,000	$94,448	$5,800,000

Intangibles_Details_1

Intangibles (Details 1) (USD $)	Sep. 30, 2014
Estimated amortization expense for intangible assets
2014	$1,391
2015	5,555
2016	5,555
2017	5,555
2018	$5,555

Intangibles_Details_Textual

Intangibles (Details Textual) (USD $)	9 Months Ended		12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2012	Dec. 31, 2013
Intangible (Textual)
Fee of gross receipts of Licensee, Percentage	6.00%
Term of license agreement	20 years
Amortization period of license agreement	19 years 6 months
Fair value of the license	$90,284		$100,000	$94,448
Impairment loss			-5,392,308
Amortization	($4,164)	($4,164)

Loan_Receivable_Details

Loan Receivable (Details) (USD $)	4 Months Ended
	Aug. 10, 2012	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012	Feb. 03, 2012
Loan Receivable (Textual)
Issuance of debt to Health Clinics of Florida					$32,000
Additional advance to Health Clinics of Florida on April 9, 2012 and August 10, 2012	10,500
Interest on outstanding balance, per annum					10.00%
Loan receivable - net of allowance
Allowances for bad debts		$42,500	$42,500	$42,500

Debt_Details

Debt (Details) (USD $)	Sep. 30, 2014		Dec. 31, 2013		Dec. 31, 2012
Summary of short-term debt
Short-term Debt to Related Parties, current	$1,050,905		$779,133		$737,200
Less: Current portion	1,050,905		779,133
Short-term debt to related parties net
Unsecured promissory note, interest free, due April 15, 2015 (1)
Summary of short-term debt
Short-term Debt to Related Parties, current	200,000	[1]	200,000	[1]
Unsecured promissory note, interest free, due April 15, 2015 (2)
Summary of short-term debt
Short-term Debt to Related Parties, current	75,000	[2]	75,000	[2]
Unsecured promissory note, interest free, due April 15, 2015 (2)
Summary of short-term debt
Short-term Debt to Related Parties, current	60,000	[2]	60,000	[2]
Unsecured promissory notes, interest @ 10% per annum, due April 15, 2015 (3)
Summary of short-term debt
Short-term Debt to Related Parties, current	75,000	[3]	75,000	[3]
Unsecured promissory notes, interest free due April 15, 2015 (4)
Summary of short-term debt
Short-term Debt to Related Parties, current	347,200	[4]	347,200	[4]
Unsecured promissory note, interest free, due on demand (5)
Summary of short-term debt
Short-term Debt to Related Parties, current	193,705	[5]	21,933	[5]
Unsecured promissory note, interest free, due January 15, 2015 (9)
Summary of short-term debt
Short-term Debt to Related Parties, current	$100,000	[6]		[6]
[1]	On January 5, 2012, LMC borrowed $200,000 from the Dellinger Fund, a shareholder of the Company. The note is interest free and has been extended to April 15, 2015. In the event of default, the Dellinger Fund has the right to request and will be granted the issuance of two million shares of the Company's common stock.
[2]	On February 3, 2012 and March 1, 2012, LMC borrowed $75,000 and $60,000, respectively, from the Dellinger Fund, a shareholder of the Company. The unsecured notes are interest free and are due April 15, 2015. In the event of default, interest on the outstanding balance shall accrue at a rate of ten percent (10%) per annum from the date of the default.
[3]	On April 3, 2012, LMC borrowed $75,000 from the Dellinger Fund, a shareholder of the Company. The unsecured note bears interest @ 10% per anum and is due April 15, 2015. In the event of default, interest on the outstanding balance shall continue to accrue at a rate of ten percent (10%) per annum from the date of the default.
[4]	On various dates from March 23, 2012 through November 26, 2012, LMC borrowed $327,200 from the Dellinger Fund, a shareholder of the Company. In February 2013, LMC borrowed an additional $20,000. The unsecured notes are interest free and are due April 15, 2015. In the event of a default, interest on the outstanding balance shall accrue at a rate of ten percent (10%) per annum from the date of the default.
[5]	During the year ended December 31, 2013 and the nine months ended September 30, 2014, Saddleworth Ventures LLC, a related party, paid expenses amounting to $21,933 and $171,772, respectively, on behalf of the Company. These advances are unsecured, interest free and are due on demand.
[6]	In February 2014, the Company received from Saddleworth Ventures an advance of $100,000 that was used as an initial down payment for an acquisition. The advance is interest free and due January 15, 2015. Saddleworth Ventures has the option to convert the note representing the advance, in whole or in part, into shares of the Company's common stock at a price of $0.10 per share.

Debt_Details_1

Debt (Details 1) (USD $)	Sep. 30, 2014		Dec. 31, 2013
Short term debt
Short-term debt	$251,000		$176,000
Less: Current portion	251,000		176,000
Short term debt net
Unsecured promissory note, interest free, due on demand (6)
Short term debt
Short-term debt	26,000	[1]	26,000	[1]
Secured promissory note, interest @ 12% per annum, due December 15, 2014 (7)
Short term debt
Short-term debt	150,000	[2]	150,000	[2]
Unsecured promissory note, interest @ 10%, due December 15, 2014 (8)
Short term debt
Short-term debt	$75,000	[3]		[3]
[1]	On May 13, 2013, LMC borrowed $30,000 from Forbes Investment, LLP. The unsecured note is interest free and payable upon demand. In December 2013, LMC repaid $4,000 against the outstanding balance.
[2]	On October 16, 2013, LMC borrowed $150,000 from Edmund Malits, a shareholder of the Company. The secured note bears interest @ 12% per annum and interest and principal are payable in full on or before February 16, 2014. LMC provided the Corporation's shell on the OTCBB as collateral for the loan. In addition, LMC issued Edmund Malits 500,000 shares of the Company's common stock with a fair value of $10,000. The note has been extended to December 15, 2014.
[3]	On February 4, 2014, the Company executed an unsecured promissory note with Curt Maes and received $75,000. The promissory note bears interest @ 10% per annum and both principal and interest are payable on or before December 15, 2014. As additional consideration, the Company issued Curt Maes 250,000 shares of the Company's common stock valued @ $25,000.

Debt_Details_Textual

Debt (Details Textual) (USD $)

0 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

1 Months Ended

2 Months Ended

1 Months Ended

12 Months Ended

0 Months Ended

Feb. 04, 2014

Oct. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Feb. 06, 2012

Mar. 01, 2012

Apr. 03, 2012

Feb. 28, 2013

Nov. 26, 2012

Dec. 31, 2013

Oct. 16, 2013

Jan. 05, 2012

Feb. 03, 2012

Feb. 21, 2013

13-May-13

Debt (Textual)

Fund borrowed from related parties

$100,000

$100,000

$20,000

Interest expense

12,375

1,875

57,000

5,625

Issuance of common stock

25,000

10,000

Issuance of common stock, shares

250,000

500,000

Unsecured promissory note, interest free, due April 15, 2015 (1)

Debt (Textual)

Debt Instrument, Maturity Date

15-Apr-15

Fund borrowed from related parties

200,000

Issuance of common stock, shares

2,000,000

Unsecured promissory note, interest free, due April 15, 2015 (2)

Debt (Textual)

Debt instrument interest rate

10.00%

10.00%

Debt Instrument, Maturity Date

15-Apr-15

Fund borrowed from related parties

200,000

75,000

Unsecured promissory note, interest free, due April 15, 2015 (2)

Debt (Textual)

Debt instrument interest rate

10.00%

Debt Instrument, Maturity Date

15-Apr-15

Fund borrowed from related parties

60,000

Unsecured promissory notes, interest @ 10% per annum, due April 15, 2015 (3)

Debt (Textual)

Debt instrument interest rate

10.00%

Debt Instrument, Maturity Date

15-Apr-15

Fund borrowed from related parties

75,000

Unsecured promissory notes, interest free due April 15, 2015 (4)

Debt (Textual)

Debt instrument interest rate

10.00%

10.00%

Debt Instrument, Maturity Date

15-Apr-15

15-Apr-15

Fund borrowed from related parties

20,000

327,200

347,200

Unsecured promissory note, interest free, due on demand (5)

Debt (Textual)

Fund borrowed from related parties

171,772

171,772

21,933

Unsecured promissory note, interest free, due on demand (6)

Debt (Textual)

Fund borrowed from related parties

30,000

Repayment of debt

4,000

Secured promissory note, interest @ 12% per annum, due December 15, 2014 (7)

Debt (Textual)

Debt instrument interest rate

12.00%

Debt Instrument, Maturity Date

15-Dec-14

16-Feb-14

Fund borrowed from related parties

150,000

Issuance of common stock

10,000

Issuance of common stock, shares

500,000

Unsecured promissory note, interest @ 10%, due December 15, 2014 (8)

Debt (Textual)

Debt instrument interest rate

10.00%

Debt Instrument, Maturity Date

15-Dec-14

Fund borrowed from related parties

75,000

25,000

25,000

Issuance of common stock

25,000

Issuance of common stock, shares

250,000

Unsecured promissory note, interest free, due January 15, 2015 (9)

Debt (Textual)

Debt Instrument, Maturity Date

15-Jan-15

Fund borrowed from related parties

$100,000

$100,000

Common stock price per share

$0.10

$0.10

Accounts_Payable_and_Accrued_E2

Accounts Payable and Accrued Expenses (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Accrued expenses
Interest	$44,900	$16,650
Salaries - Officer	5,000	13,250
Rent		22,418
Other	41,911	35,992
Accounts payable and Accrued expenses, Total	$91,811	$88,310

Stockholders_Equity_Details

Stockholders' Equity (Details) (USD $)	0 Months Ended	12 Months Ended
	Feb. 08, 2012	Dec. 31, 2012
Stockholders Equity (Textual)
Stock issued for services to Saddleworth consulting	19,000,000
Outstanding principal balance exchange for the shares by Saddleworth Consulting	$3,000,000
Interest accrued on notes payable (WMA notes)	165,000
Stock issued for service to saddleworth consulting, Value	3,800,000
Loss on extinguishment of debt		$654,657

StockBased_Compensation_Detail

Stock-Based Compensation (Details) (USD $)	0 Months Ended	1 Months Ended	9 Months Ended
	Feb. 04, 2014	Oct. 31, 2013	Sep. 30, 2014	Sep. 30, 2013
Stock Based Compensation (Textual)
Stock issued related to share based compensation			0	130,000
Share based compensation expenses			$0	$11,550
Issuance of common stock	$25,000	$10,000
Issuance of common stock, shares	250,000	500,000

Warrants_Details

Warrants (Details) (Warrant [Member], USD $)	9 Months Ended
	Sep. 30, 2014
Warrant [Member]
Summary of changes in warrants outstanding and related price of shares
Outstanding, Number, Beginning Balance	2,400,000
Warrants, Granted
Warrants, Expired/Cancelled
Warrants, Exercised
Warrants Outstanding, Ending Balance	2,400,000
Exercisable, Number	2,400,000
Outstanding, Weighted Average Exercise Price, Beginning Balance	$0.20
Weight Average Exercise price, Warrant Granted
Weight Average Exercise price, Warrant Expired/Cancelled
Weight Average Exercise price, Warrant exercised
Outstanding, Weight Average Exercise Price - Ending Balance	$0.20
Exercisable, Weighted Average Exercise Price	$0.20

Warrants_Details_Textual

Warrants (Details Textual) (USD $)	0 Months Ended	9 Months Ended
	Feb. 06, 2012	Sep. 30, 2014	Sep. 30, 2013
Warrant (Textual)
Number of warrants issued as compensation	2,400,000
Warrants maturity date		6-Feb-17
Expected term	3 years
Risk free interest rate	0.32%
Dividend yield	0.00%
Volatility rate	432.00%
Fair value of warrant included in Company's consolidated statement of operations	$479,912
Term of warrant amortization description		Over 3 years
Warrant expenses		$118,335	$118,335

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	3 Months Ended			9 Months Ended			12 Months Ended
	Sep. 30, 2014		Sep. 30, 2013	Sep. 30, 2014		Sep. 30, 2013	Dec. 31, 2011	Dec. 31, 2013		Dec. 31, 2012
Related Party Transaction (Textual)
Fund borrowed from related parties	$100,000			$100,000				$20,000
Expenses paid on behalf of the company								21,933
Short-term debt to related parties	1,050,905			1,050,905				779,133		737,200
Interest expense	12,375		1,875	57,000		5,625
MPL License Agreement [Member]
Related Party Transaction (Textual)
Purchase price of License							6,000,000
Payment for licensing agreement							3,000,000
Consulting agreement with Saddleworth Ventures [Member]
Related Party Transaction (Textual)
Consultation fees				0		0
Expenses paid on behalf of the company	171,772			171,772				21,933
Unsecured promissory note, interest free, due January 15, 2015 (9)
Related Party Transaction (Textual)
Fund borrowed from related parties	100,000			100,000
Sale of Stock, Price Per Share	$0.10			$0.10
Short-term debt to related parties	$100,000	[1]		$100,000	[1]				[1]
[1]	In February 2014, the Company received from Saddleworth Ventures an advance of $100,000 that was used as an initial down payment for an acquisition. The advance is interest free and due January 15, 2015. Saddleworth Ventures has the option to convert the note representing the advance, in whole or in part, into shares of the Company's common stock at a price of $0.10 per share.

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (USD $)	1 Months Ended	9 Months Ended		0 Months Ended
	Jan. 31, 2012	Sep. 30, 2014	Sep. 30, 2013	Jul. 01, 2012
Consulting agreements with third parties [Member]
Commitments and Contingencies (Textual)
Term of consulting agreement	3 years
Payment issued to consultant upon execution of agreement	$25,000	$0	$0
Consultation fees		67,500	5,666
Employment agreement with Christopher Smith [Member]
Commitments and Contingencies (Textual)
Term of consulting agreement				5 years
Payment issued to consultant upon execution of agreement				60,000
Amount of compensation as per payroll - officer		$45,000	$45,000

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	0 Months Ended
	Feb. 08, 2012	Dec. 27, 2011	Apr. 17, 2015	Apr. 01, 2015	Sep. 30, 2014	Dec. 31, 2013	Apr. 10, 2015
Subsequent Event (Textual)
Purchase consideration		$3,000,000
Principal amount of convertible debt	3,800,000
Debt conversion, Converted instrument, Shares issued	19,000,000
Deposit amount					100,000
Subsequent Event [Member]
Subsequent Event (Textual)
Principal amount of convertible debt			757,200
Debt conversion, Converted instrument, Shares issued			6,000,000
Deposit amount							100,000
Subsequent Event [Member] | Director [Member]
Subsequent Event (Textual)
Purchase consideration				$2,500,000
Warrants issued to purchase common stock			5,000,000
Warrant expiration date			17-Apr-22
Warrant exercise price			$0.09